A PHASE III OPEN-LABEL, SINGLE-ARM, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF BRIGIMADLIN (BI 907828) TREATMENT IN PATIENTS WITH TREATMENT-NAÏVE OR PRE-TREATED ADVANCED DEDIFFERENTIATED LIPOSARCOMA

Registry ID

1403-0019

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Start date

2025-03-31

Completion date

2026-01-14

Last update

2023-11-16

Conditions

• LIPOSARCOMA

Related clinical trials

• A PHASE 2 SINGLE ARM OPEN-LABEL CLINICAL TRIAL OF ADP-A2M4 SPEAR T CELLS IN SUBJECTS WITH ADVANCED SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA (SPEARHEAD 1 STUDY)
• A PHASE 2-3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF SELINEXOR (KPT-330) VERSUS PLACEBO IN PATIENTS WITH ADVANCED UNRESECTABLE DEDIFFERENTIATED LIPOSARCOMA (DDLS)

View on source registry